echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JCEM: Empagliflozin reduces kidney stone risk

    JCEM: Empagliflozin reduces kidney stone risk

    • Last Update: 2022-04-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Kidney stones are a common problem with an estimated global prevalence of up to 15%


    diabetes

    A recent observational study found that sodium-glucose cotransporter 2 inhibitors were associated with a 49% lower risk of kidney stones in patients with type 2 diabetes compared with GLP-1 receptor agonists


    We pooled data from 20 phase I-IV trials, including the large CV outcomes trial EMPA-REGOUTCOME, on 15,081 patients with type 2 diabetes who were randomized to empagliflozin (n=10177) or placebo ( n=4904) treatment


    Median exposure to study drug was 543 days (placebo) and 549 days (empagliflozin)


    Thus, the underlying mechanisms remain unclear, and dedicated randomized prospective clinical trials are warranted to confirm these preliminary observations in patients with and without type 2 diabetes


    Thus, the underlying mechanisms remain unclear, and dedicated randomized prospective clinical trials are warranted to confirm these preliminary observations in patients with and without type 2 diabetes


    Original source:

    Priyadarshini Balasubramanian, et al.


    Empagliflozin and decreased risk of nephrolithiasis: A potential new role for SGLT2 inhibition?

    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.